Run2Cure will be held for the fourth time on Sunday, the 4th June 2017 in the wonderful and iconic location of the Domain in Sydney.

This pram friendly, family friendly event is a great way to get together a group to take part in the 3k, 5k or 10k runs while for children 5 years and under there is a 1k event. The day will feature lots of entertainment for the children including face painting, jumping castles, pony rides, kindy farm, rock climbing wall, craft activities, mini soccer and cricket, “Chloe’s Challenge Obstacle Course” and other garden games. The aim of this event is to raise awareness of, and funds for, neuroblastoma childhood cancer research.



Run2Cure has now raised over $430 000 for designated neuroblastoma research projects. In 2017 our aim is to raise $150 000 for Children’s Cancer Institute and Cancer Council NSW to conduct vital research into neuroblastoma. We know with more research being funded, treatments can improve – allowing more children to beat this devastating disease. Our vision as a charity – started by parents affected by neuroblastoma – is to ensure all children have the chance to grow up and lead long and healthy lives, without side effects from their treatments.


7.30am – timed 10k fun run
9.00 am – timed 5k fun run
9.10am – timed 3k  fun run
10.30am – ‘The Little Heroes 1k’ walk for children five and under with their families very welcome too! Children are encouraged to dress up as superheroes! This is a walk for children by children as neuroblastoma is a cancer affecting this age group.
9.00am – 1.00pm – Children’s activities

For more information:

There is a separate website for Run2Cure where you can read more about the event and register for the fun runs. There are also some great fundraising prizes.

If you are interested in helping us make this event an even bigger success, by volunteering or sponsoring, please email us at

Thanks again to all our sponsors, many of whom have supported this event for over 4 years. Without their help, Run2Cure would simply not be possible.

RESEARCH NEWS: Burtomab has just been designated by the US Food and Drug Administration as a breakthrough drug for children with relapsed or refractory neuroblastoma with central nervous system or leptomeningeal metastasis. This will speed up the time it takes to make this therapy available to the children. Currently there are no drugs available to treat this type of advance neuroblastoma. For more details see: ...

Neuroblastoma Australia
Ste 3, 165 Sailors Bay Rd
Northbridge NSW 2063
0406 991 606
Neuroblastoma Australia Incorporated is a registered charity with GDR Status . ABN 74 173 375 414.